Preclinical Investigations Reveal the Broad-Spectrum Neutralizing Activity of Peptide Pep19-2.5 on Bacterial Pathogenicity Factors

Novel Bacterial Lipoprotein Structures Conserved in Low-GC Content Gram-positive Bacteria Are Recognized by Toll-like Receptor 2

(2012) Kenji Kurokawa et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Biophysical Mechanisms of Endotoxin Neutralization by Cationic Amphiphilic Peptides

(2011) Yani Kaconis et al.   BIOPHYSICAL JOURNAL

Novel Therapies for Septic Shock Over the Past 4 Decades

(2011) Anthony F. Suffredini et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Designing antimicrobial peptides: form follows function

(2011) Christopher D. Fjell et al.   NATURE REVIEWS DRUG DISCOVERY

New Antiseptic Peptides To Protect against Endotoxin-Mediated Shock

(2010) T. Gutsmann et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Non-antibiotic strategies for sepsis

(2009) J. Cohen   CLINICAL MICROBIOLOGY AND INFECTION

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

(2009) R Phillip Dellinger et al.   CRITICAL CARE MEDICINE

Targeting the lipopolysaccharides: still a matter of debate?

(2009) Raquel Nahra et al.   Current Opinion in Anesthesiology

Comparative analysis of selected methods for the assessment of antimicrobial and membrane-permeabilizing activity: a case study for lactoferricin derived peptides

(2008) Susana Sanchez-Gomez et al.   BMC MICROBIOLOGY

Once is not enough: clinical trials in sepsis

(2008) Daniel A. Sweeney et al.   INTENSIVE CARE MEDICINE

A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo

(2008) Jian-Dong Ren et al.   INTERNATIONAL IMMUNOPHARMACOLOGY